You are here: Industry Insights > PE

News List

Private equity firms acquiring top CMOs at a rapid rate: GlobalData expresspharma
July 30, 2021
GlobalData’s report states that PE-backed CMOs will find they have a lot more financial support to add to their service offerings and value.
Fortacin™ Receives Strong Positive Results for US Phase II PRO Validation Study prnasia
July 16, 2021
Endurance RP Limited is pleased to announce the successful completion of prespecified data analysis from the United States study mandated patient reported outcome for PE.
Alembic Pharma gets tentative US FDA nod for generic Rivaroxaban tablets expresspharma
June 23, 2020
The tablet is the generic of Janssen Pharmaceuticals's reference listed drug product Xarelto.
ᴅ-dimer Test Adjusted to Clinical Probability IDs Low Risk for PE drugs
December 19, 2019
Low clinical pretest probability (C-PTP) and a ᴅ-dimer of less than 1,000 ng/mL identify patients with a low risk for pulmonary embolism ...
ESC Guidelines Updated for Diagnosis, Treatment of PE drugs
September 05, 2019
In guidelines developed by the European Society of Cardiology, in collaboration with the European Respiratory Society...
Pregnancy-Adapted Algorithm Avoids Diagnostic Imaging for PE drugs
March 21, 2019
A pregnancy-adapted algorithm can safely avoid diagnostic imaging in a proportion of pregnant women with suspected pulmonary embolism, according to a study published in the March 21 issue of the New England Journal of Medicine.
Calculus Capital invests in biotech company biospectrumasia
August 18, 2017
PE firm backs biotech company Axol supplies high-quality human cells, created by stem cell technology, to many of the world's biggest and best-known pharma companies.